Old Web
English
Sign In
Acemap
>
authorDetail
>
satou take ken
satou take ken
Viability assay
Pravastatin
DNA
HMG-CoA reductase
Biology
7
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Glecaprevir+Pibrentasvir併用療法の糖質・脂質代謝,体組成分布に対する影響
2020
Daimaoshu Tian
kou sima you yuki
motomura kenta
nakamuta makoto
satou take ken
tada yasusi ya
sugimoto rie
ooho aritune
kotou kazuhiro
desongcheng
yokota masaki
oyanagi nen sei
turuta satosi
guojizhengmei
morizono syuu suke
utimura koutarou
benduozhengzhi
tiantianshensi
tanaka seigou
katou masaki
Show All
Source
Cite
Save
Citations (0)
Genotype1型C型慢性肝炎に対するOmbitasvir+Paritaprevir/Ritonavir併用療法の実臨床における有効性と安全性―多施設共同研究―
2017
yamasita naoki
motomura kenta
kou sima you yuki
katou masaki
higuti no niti to
sakai hironori
yokota masaki
desongcheng
utimura koutarou
tada yasusi ya
morizono syuu suke
oyanagi nen sei
sugimoto rie
satou take ken
nakamuta makoto
Show All
Source
Cite
Save
Citations (0)
デルタ肝炎例におけるHBV,HDV genotypeの分子疫学的解析
2016
tamada youko
miya mei tosimitu
sanba satosi
taura naota
satou take ken
abiru seigou
nakao kazuhiko
yatuhasi hirosi
Show All
Source
Cite
Save
Citations (0)
THE EFFECTS OF PRAVASTATIN,AN HMG-CoA REDUCTASE INHIBITOR,ON CELL VIABILITY AND DNA PRODUCTION OF RAT HEPATOCYTES(プラバスタチン、HMG-CoA還元酵素阻害剤のラット肝細胞の細胞生存率とDNA合成に与える影響)
1998
satou take ken
Show All
Source
Cite
Save
Citations (0)
1